School of Medicine

Showing 1-63 of 63 Results

  • Crystal Mackall

    Crystal Mackall

    Ernest and Amelia Gallo Family Professor and Professor of Pediatrics and of Medicine

    Current Research and Scholarly Interests Recent clinical studies, by us and others, have demonstrated that T cell based immunotherapy can eradicate cancers resistant to all other available therapies. Our program creates, develops and optimizes genetically engineered T cells to treat cancer. We link the bench with the bedside, developing novel therapies for early phase testing in clinical trials, while simultaneously conducting intensive studies on clinical samples obtained from patients treated on immunotherapy trials.

  • David Magnus, Ph.D.

    David Magnus, Ph.D.

    Thomas A. Raffin Professor in Medicine and Biomedical Ethics and Professor (Teaching) of Medicine (Primary Care and Population Health)

    Current Research and Scholarly Interests Genetic testing, gene therapy, genetically engineered organisms, and the history of eugenics. Stem cell research and cloning, and egg procurement. Examining ethical issues in reproductive technologies. Organ transplantation – including donation after cardiac death, ethics of listing decisions. End of life issues in both adults and children.

  • Kenneth Mahaffey

    Kenneth Mahaffey

    Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center

    Bio Clinical Focus: Cardiovascular Medicine

    Research Focus:

    My primary research interest is the design and conduct of multicenter clinical trials and analyses of important clinical cardiac issues using large patient databases. My research focuses on novel anticoagulation agents for the treatment of acute coronary syndromes and atrial fibrillation, the study of agents targeted to protect the myocardium during reperfusion therapy for acute myocardial infarction, and the evaluation of cardiovascular safety of diabetic therapies. I am also interested in the methodology of clinical trials. Current research activities include standardization of the definition of myocardial infarction used in clinical trials, the adjudication of suspected clinical endpoint events by Clinical Event Committees (CEC), and the efficient operational conduct of large multinational clinical trials.

    Administrative Focus: Vice Chair of Clinical Research in the Department of Medicine and Member of the Stanford IRB

    Professional Training:

    1985 Stanford University, BS Chemistry
    1989 University of Washington, MD
    1993 University of Arizona, Internship/Residency/Chief Residency
    1996 Duke University, Fellowship in Cardiology
    1996 Duke University, Faculty in Cardiology
    2013 Stanford University, Vice Chair of Clinical Research, Department of Medicine

  • Megan Mahoney

    Megan Mahoney

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Stanford Primary Care delivers innovative, high-quality, personalized and holistic care for patients and families throughout their lives. We are leading the shift from a health care system focused on medical care for individual patients toward an integrated health system focused on health and wellness of a population. Stanford Primary Care partners with multiple stakeholders across Stanford Health Care and Stanford University to achieve the quadruple aim.

  • Anurag Mairal

    Anurag Mairal

    Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine

    Bio Dr. Anurag Mairal is a Consulting Associate Professor of Medicine and the Director, Global Exchange Program at Stanford Byers Center for Biodesign, Stanford University. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs. He is part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, a graduate-level course offered to engineering, business, and medical students at Stanford University. He also has additional appointments as an Adjunct Professor at Stanford Graduate School of Business and Faculty Fellow at the Center for Innovation in Global Health. As a Co-Director of the India Biodesign Phase II initiative, he leads the Forum, a platform for supporting India's medtech entrepreneurs. As the Chair of a BME IDEA APAC, a new initiative to bring together medtech innovation programs in Asia Pacific region, he is focused on building a sustainable organization that supports the needs of innovation stakeholders in the region. Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry.

    Dr. Mairal has an extensive background in medical technology development and commercialization, collaborating with partners in the U.S., India, China, and other emerging markets to advance product development, manufacturing, and distribution. Recently, he took two years off from Orbees Medical to take a senior leadership role at PATH, a major global health nonprofit based in Seattle. In this role, he oversaw research and development, commercialization, and implementation of technologies in PATH's medical devices, diagnostics, and digital health divisions. Previously, he held several positions at Johnson & Johnson, including Business Development Director and Product Director for structural heart, cardiology, and peripheral vascular products at Cordis. Before joining J&J, he was a Group Leader and a Process Development Manager at Membrane Technology and Research (MTR). At MTR, he was responsible for business development, strategic alliances, and product development in the bioseparations area. An active mentor to entrepreneurs and industry professionals, he serves on the boards of several for-profit and non-profit organizations and is a Charter Member at EPPIC Global Network.

    Dr. Mairal earned a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the University of California at Berkeley. He also holds an MS in chemical engineering from the Indian Institution of Technology in Mumbai and a BS in chemical engineering from National Institute of Technology, Raipur. Dr. Mairal was a post-doctoral fellow at the University of Twente, Netherlands and at University of Michigan, Ann Arbor. Dr. Mairal has an MBA from the Haas School of Business at University of California, Berkeley. At Haas, he was a founding co-Chairman of the South Asia Business Conference and Chair of the Biotech Panel for the Asia Business Conference. His work has been published in more than 30 publications, and he has been issued seven patents.

  • Ravindra Majeti MD, PhD

    Ravindra Majeti MD, PhD

    Professor of Medicine (Hematology)

    Current Research and Scholarly Interests The Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.

  • Joshua Makower

    Joshua Makower

    Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Josh Makower serves on the faculty of the Stanford University Medical School as an Adjunct Professor of Medicine and is Co-Founder of Stanford?s Biodesign Innovation Program (now called the Byers Center for Biodesign). Josh helped create the fundamental structure of the Center?s core curriculum and is the chief architect of what is now called ?The Biodesign Process.? Over the past 18 years since Josh and Dr. Paul Yock founded the Stanford Biodesign Innovation Program, this curriculum and the associated textbook has been used at Stanford and across the world to train thousands of students, faculty and industry leaders on the biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 8 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, Nuelle and Willow. Josh is currently also working with NEA where he is a General Partner on their healthcare team leading the medtech/healthtech practice. Josh serves on the board of Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor?s degree in Mechanical Engineering from MIT and is a Member of the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.

  • Jose R. Maldonado, MD, FAPM

    Jose R. Maldonado, MD, FAPM

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Emergency Medicine and of Medicine at the Stanford University Medical Center and, by courtesy, of Law

    Current Research and Scholarly Interests Pathophysiology and Management of Delirium, Acute Brain Failure and Cognitive Impairment, Neuropsychiatric Sequelae of Traumatic Brain Injury, Factitious Disorder & Munchausen's Syndrome, Cultural Diversity in Medical Care, Psychiatric Complications of Bone Marrow Transplantation, Conversion Disorder, Depression in the Medically Ill, Neuropsychiatric Sequelae of Chronic Fatigue Syndrome.

  • Sanjay Malhotra

    Sanjay Malhotra

    Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology), of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Medicine (Oncology)

    Current Research and Scholarly Interests My research interests focus on the design and discovery of synthetic, and natural product inspired small molecules which can be used as probes for developing understanding of biological phenomena, including protein-protein interactions and modulation of signal transduction pathways. My laboratory employs the tools of synthetic medicinal chemistry, molecular modeling and chemical biology for translational research in drug discovery, development, imaging and radiation.

  • Robert Marcus

    Robert Marcus

    Professor (Clinical) of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus

    Current Research and Scholarly Interests I have been retired since 2008 and no longer conduct research

  • David J. Maron

    David J. Maron

    Clinical Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Dr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.

  • Marina Martin

    Marina Martin

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Providing quality interdisciplinary care to older patients with complex conditions, dementia, or frailty
    Health care delivery in low-income and low English proficiency communities
    Improving health care delivery systems for older adults, particularly those with advanced illness and caregiver dependence
    Advance care planning

  • Suleiman Alfred Massarweh

    Suleiman Alfred Massarweh

    Associate Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests My work is focused in investigating mechanisms of endocrine resistance in ER-positive breast cancer and novel clinical trial designs of combined ER and targeted therapeutics. Primary areas of investigation are in metastatic disease and preoperative clinical trials.
    Additional areas of interest include breast cancer in young women, in men, and breast cancer diagnosed during pregnancy.

  • Michael V. McConnell, MD, MSEE

    Michael V. McConnell, MD, MSEE

    Clinical Professor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests My imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.

    My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health to enhance heart-healthy activities in patients and populations.

  • Ian McCoy

    Ian McCoy

    Clinical Instructor, Medicine - Nephrology

    Current Research and Scholarly Interests As a nephrologist working in diverse practice settings including the intensive care unit (ICU), I regularly face the limitations of current clinical tools for assessing a patient's volume status and for guiding patient selection for diuretic therapy. I work with a large, detailed clinical database (MIMIC-III) to study current patterns of diuretic use in the ICU, estimated effects of diuretic use, and clinical features that may predict outcomes in critically ill patients receiving diuretics.

    I am also involved in quality improvement. I lead the Draw on Dialysis project, which aims to draw non-urgent inpatient labs on dialysis rather than by peripheral phlebotomy in order to save patient pain and peripheral veins for future dialysis access. I am also interested in leveraging nationwide databases such as Optum claims data to assess adherence to guidelines in kidney care.

  • Mark McGovern

    Mark McGovern

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Medicine (Primary Care and Population Health) at the Stanford University Medical Center

    Current Research and Scholarly Interests We use innovations from implementation science to improve public access to effective treatments for all health problems and especially behavioral health problems, including addiction and mental health disorders. Our credo is NO HEALTH WITHOUT BEHAVIORAL HEALTH. Our goal is to enhance a person's chances for the best outcomes possible, including a lifetime of recovery. We embrace our leadership role to advance the science of implementation and mentor the next generation of researchers.

  • Tracey McLaughlin

    Tracey McLaughlin

    Professor of Medicine (Endocrinology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. McLaughlin conducts a number of clinical research studies related to obesity, insulin resistance, diabetes, and cardiovascular disease. Current studies include: 1) the impact of macronutrient composition on weight loss and cardiocascular risk (diabetic and nondiabetic patients); 2) comparison of weight loss and cardiovascular risk reduction in diabetic patients treated with different classes of antihyperglycemic drugs; 3) the role of the adipocyte in modulating insulin resistance

  • Bruno Medeiros

    Bruno Medeiros

    Adjunct Clinical Associate Professor, Medicine - Hematology

    Current Research and Scholarly Interests My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.

  • Mads Melbye

    Mads Melbye

    Academic Staff - Hourly - CSL, Medicine - Primary Care and Population Health

    Bio Mads Melbye is Visiting Professor at Stanford University School of Medicine, and President and CEO at Statens Serum Institut in Copenhagen, Denmark. Previous positions at e.g. the National Cancer Institute, NIH, USA, before he became State Epidemiologist in Denmark, and later Head of Department of Epidemiology Research, Director of Division of Epidemiology, Director of Division of Epidemiology and Disease Surveillance and The Danish National Biobank and most recently CEO of Statens Serum Institut in Copenhagen, Denmark. Previous academic positions as Danish Research Council Professor, NORFA professor, Foreign Adjunct Professor at Karolinska Institute in Sweden, and Professor in Medical Epidemiology at Copenhagen University. He has written more than 590 publications (H-index: 88 (Web of Science), 110 (Google Scholar)) and is the Dane with most papers in high impact journals in general medicine (NEJM, Lancet, JAMA).

  • Michelle Mello

    Michelle Mello

    Professor of Law and of Medicine (Primary Care and Outcomes Research)

    Bio Michelle Mello is a leading empirical health law scholar whose research is focused on understanding the effects of law and regulation on health care delivery and population health outcomes. She is the author of more than 190 articles and book chapters on the medical malpractice system, medical errors and patient safety, public health law, regulation pf pharmaceuticals, biomedical research ethics and governance, obesity policy, and other topics. The recipient of a number of awards for her research, she was elected to the National Academy of Medicine at the age of 40.

    From 2000 to 2014, Dr. Mello was a professor at the Harvard School of Public Health, where she directed the School?s Program in Law and Public Health. She has also served as a Lab Fellow at Harvard University?s Edmond J. Safra Center for Ethics.

    Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University.

  • Mark Mercola

    Mark Mercola

    Professor of Medicine (Cardiovascular)

    Bio Dr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.

    Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.

    Prof. Mercola received an NIH MERIT award for his work on heart formation, and authored over 130 papers. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences,, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the NIH, California Institute for Regenerative Medicine and the Fondation Leducq.

  • Thomas Charles Merigan M.D.

    Thomas Charles Merigan M.D.

    George E. and Lucy Becker Professor of Medicine, Emeritus

    Current Research and Scholarly Interests I am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.

  • Everett Meyer

    Everett Meyer

    Assistant Professor of Medicine (Blood and Marrow Transplantation) and of Pediatrics (Stem Cell Transplantation) at the Stanford University Medical Center

    Current Research and Scholarly Interests Research focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.

  • Timothy Meyer

    Timothy Meyer

    Stanford University Professor of Nephrology

    Current Research and Scholarly Interests Inadequate removal of uremic solutes contributes to widespread illness in the more than 350,000 Americans maintained on hemodialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.

  • David Miklos

    David Miklos

    Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Miklos is the Clinical Director of Stanford University?s Center for Cancer Cell Therapy, and leads Stanford?s CAR therapy clinical trials for patients with aggressive lymphomas: 1) Phase I CAR19-22 Safety and efficacy outcomes ? the first bispecific CAR-T study for patients with rel/refractory DLBCL and ALL, 2) CAR19 CD4-CD8 immune phenotyping following various CAR-T, 3) Mechanisms for CAR-T DLBCL treatment Failure

  • Arnold Milstein

    Arnold Milstein

    Professor of Medicine (General Medical Discipline)

    Current Research and Scholarly Interests Design and national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.

    Research on creation of a national index of health system productivity gain.

  • Beverly S. Mitchell, M.D.

    Beverly S. Mitchell, M.D.

    George E. Becker Professor in Medicine and Professor, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly Interests Beverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.

  • Minal Moharir

    Minal Moharir

    Clinical Assistant Professor, Medicine - Vaden Health Center

    Bio I was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.

  • Kegan Moneghetti MBBS (hons), FRACP, PhD

    Kegan Moneghetti MBBS (hons), FRACP, PhD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    Bio I am a cardiologist and researcher with specialty interests in sports medicine, heart failure and exercise testing. My background includes clinical training in internal medicine and cardiology through the Royal Australasian College of Physicians. I have completed an advance cardiac imaging fellowship (Monash Heart) and a post doctoral fellowship in exercise physiology (Stanford University). I have a clinical interest cardiovascular health in those wanting to be active or who regularly exercise (athletes and non-athletes). My current research projects are aimed at defining inflammasome/metabolic pathways with exercise and optimizing the use of demographic data to predict exercise performance in healthy individuals and those with heart failure.

  • Tamara Montacute

    Tamara Montacute

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Bio Tamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women?s health, adolescent health, preventative health, integrative & alternative medicine, chronic disease management, mental health, and travel medicine. She also speaks Spanish!

    She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O?Connor Hospital in San Jose.

    Outside the clinic, she enjoys hiking, biking, knitting, cooking, gardening, reading, doing yoga, running with her dogs and traveling.

  • Jose G. Montoya

    Jose G. Montoya

    Professor of Medicine (Infectious Diseases and Geographic Medicine) at the Stanford University Medical Center

    Bio Dr. Montoya is originally from Cali, Colombia and completed his medical degree with honors at the Universidad del Valle. He trained in Internal Medicine at Tulane University in New Orleans. Following his residency, he completed a four-year intense fellowship in Infectious Diseases at Stanford University in Palo Alto under the mentorship of Drs. Jack S. Remington and Thomas C. Merigan.

    He is currently Professor in the Department of Medicine and Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine ( He is also the founder of the Immunocompromised Host Service (Infectious Diseases) at Stanford University Medical Center. He was elected Fellow of the American College of Physicians (FACP) in recognition of commitment to the internal medicine community and Fellow of the Infectious Diseases Society of America? (FIDSA) for having achieved professional excellence in the field of Infectious Diseases

    He is also the Director of the National Reference Laboratory for the Diagnosis and Management of Toxoplasmosis in the United States at the Palo Alto Medical Foundation in Palo Alto, California ( He has authored and co-authored more than 170 publications in peer-reviewed journals along with book chapters. He has received more than 10 school-wide teaching awards at Stanford. For the past 15 years, his research endeavors have included building a multidisciplinary team at Stanford University ( focused on elucidating the central pathogenesis of Myalgic Encephalomyelitis (ME), commonly known as Chronic Fatigue Syndrome (CFS) or ME/CFS and has created a world-class ME/CFS clinic visited by patients from all over the United States and abroad.

  • Joshua Mooney

    Joshua Mooney

    Clinical Assistant Professor, Medicine - Pulmonary & Critical Care Medicine

    Current Research and Scholarly Interests Outcomes and Health Services Research in Advanced Lung Disease & Lung Transplant

  • Nancy Morioka-Douglas

    Nancy Morioka-Douglas

    Clinical Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests --Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
    --Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
    --Enhancing physician and staff satisfaction in caring for patients

  • Lori Muffly

    Lori Muffly

    Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Muffly's interests include health services research and clinical trials with a focus on acute leukemia and blood and marrow transplantation.

  • Mark Musen

    Mark Musen

    Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science

    Current Research and Scholarly Interests There are great opportunities for new discoveries and for ensuring the reproducibility of scientific results when experimental data?and descriptions of the methods used to generate and analyze those data?are available in public repositories. Our laboratory is studying the development of new methods to aid investigators in creating more comprehensive online descriptions both of their data and of their experiments that can be processed both by other scientists and by computers.

  • Bryan Myers

    Bryan Myers

    Professor of Medicine (Nephrology), Emeritus

    Current Research and Scholarly Interests A novel approach is used to evaluate glomerular disease in humans, and its progression. A combination of physiologic techniques, a morphometric analysis of glomeruli obtained by biopsy, and mathematical modeling of glomerular ultrafiltration is used to quantify the extent of glomerular injury in humans for the first time.

Footer Links:

Stanford Medicine Resources: